Terms: = Breast cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Treatment
35319 results:
1. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
[TBL] [Abstract] [Full Text] [Related]
2. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
Salim N; Tumanova K; Popodko A; Libson E
JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
[TBL] [Abstract] [Full Text] [Related]
3. Dietary supplement intake in women with breast cancer before and after diagnosis: results from the SUCCESS C trial.
Hauner D; Mang A; Donik L; Schederecker F; Meyer D; Rack B; Janni W; Hauner H
BMC Cancer; 2024 May; 24(1):591. PubMed ID: 38750410
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary.
Tang L; Zhu Y; Du Y; Long X; Long Y; Tang Y; Liu J
J Cancer Res Clin Oncol; 2024 May; 150(5):256. PubMed ID: 38750402
[TBL] [Abstract] [Full Text] [Related]
5. Practice of breast self-examination and associated factors among women of reproductive age in the North Shoa Zone, Oromia, Ethiopia, 2022: a convergent mixed-methods study.
Hussein D; Oyato BT; Gashaw K; Geleta TA; Tufa DG; Geleta LA
BMJ Open; 2024 May; 14(5):e073951. PubMed ID: 38749697
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US.
Munter-Young R; Fuentes-Alburo A; DiGregorio N; Neeser K; Gultyaev D
PLoS One; 2024; 19(5):e0302486. PubMed ID: 38743917
[TBL] [Abstract] [Full Text] [Related]
7. Leveraging G-CSF prescribing in the outpatient setting: considerations beyond clinical factors-a questionnaire study.
Scotté F; Artru P; Saghatchian M; Chouaid C
Support Care Cancer; 2024 May; 32(6):347. PubMed ID: 38743147
[TBL] [Abstract] [Full Text] [Related]
8. Longitudinal assessment of real-world patient adherence: a 12-month electronic patient-reported outcomes follow-up of women with early breast cancer undergoing treatment.
Gebert P; Hage AM; Blohmer JU; Roehle R; Karsten MM
Support Care Cancer; 2024 May; 32(6):344. PubMed ID: 38740611
[TBL] [Abstract] [Full Text] [Related]
9. Survey of awareness and beliefs about cancer (ABC) in Tehran Province, Iran.
Akbari P; Nemati S; Nahvijou A; Bolourinejad P; Forbes L; Zendehdel K
BMC Cancer; 2024 May; 24(1):579. PubMed ID: 38734656
[TBL] [Abstract] [Full Text] [Related]
10. Trastuzumab deruxtecan in previously treated HER2-positive metastatic or unresectable breast cancer: Real-life data from the temporary use authorization program in France.
Petit T; Hajjaji N; Antoine EC; Benderra MA; Gozy M; Foa C; Mouysset JL; Grenier J; Mousseau M; Mailliez A; Saghatchian M; Lachaier E; Desmoulins I; Hennequin A; Maes P; Loirat D; Ricci F; Diéras V; Berton D; Tiong FL; Teixeira L; Dohollou N; Lévy C; Bachelot T; Pierga JY
Cancer Med; 2024 May; 13(9):e7168. PubMed ID: 38733172
[TBL] [Abstract] [Full Text] [Related]
11. Exploring CDKN1A Upregulation Mechanisms: Insights into Cell Cycle Arrest Induced by NC2603 Curcumin Analog in MCF-7 breast cancer Cells.
Nishimura FG; Sampaio BB; Komoto TT; da Silva WJ; da Costa MMG; Haddad GI; Peronni KC; Evangelista AF; Hossain M; Dimmock JR; Bandy B; Beleboni RO; Marins M; Fachin AL
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732206
[TBL] [Abstract] [Full Text] [Related]
12. General practitioners' management of mastitis in breastfeeding women: a mixed method study in Australia.
Amir LH; Crawford SB; Cullinane M; Grzeskowiak LE
BMC Prim Care; 2024 May; 25(1):161. PubMed ID: 38730361
[TBL] [Abstract] [Full Text] [Related]
13. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
Tian Y; He L; Zhang B; Deng L; Wang J
Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
[No Abstract] [Full Text] [Related]
14. The role of clinical breast examination and fine needle aspiration cytology in early detection of breast cancer: A cross-sectional study nested in a cohort in a low-resource setting.
Mremi A; Pallangyo A; Mshana T; Mashauri O; Kimario W; Nkya G; Mwakyembe TE; Mollel E; Amsi P; Mmbaga BT
Womens Health (Lond); 2024; 20():17455057241250131. PubMed ID: 38725253
[TBL] [Abstract] [Full Text] [Related]
15. Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment.
Bardakci M; Karakas H; Bayram D; Avci N; Kitapli S; Ozen M; Aslan F; Koseoglu C; Kadioglu A; Onur ID; Sakalar T; Buyuksimsek M; Alkan A; Ergun Y; Kaya AO; Bilgin B; Yalcin B
Sci Rep; 2024 May; 14(1):10632. PubMed ID: 38724585
[TBL] [Abstract] [Full Text] [Related]
16. Implementing Standard Diagnosis and treatment for Locally Advanced breast cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial.
Retamales J; Daneri-Navarro A; Artagaveytia N; Alves da Quinta D; Abdelhay E; Podhajcer OL; Velázquez C; Giunta D; Crocamo S; Garibay-Escobar A; Del Toro-Arreola A; Rodriguez R; Aghazarian M; Alcoba E; Alonso I; Binato R; Bravo AI; Canton-Romero J; Carraro DM; Castro M; Castro-Cervantes J; Cataldi S; Camejo N; Cortes-Sanabria L; Flores-Marquez M; Laviña G; Musetti E; Caserta B; Cerda M; Colombo A; Delgadillo-Cristerna R; Dreyer Breitenbach M; Fernandez E; Fernandez J; Franco-Topete R; Gabay C; Gaete F; Gamboa J; García-Gaeta R; Gomez Del Toro M; Gonzalez-Ramirez LP; Guerrero M; Herrera-Miramontes M; Lopez-Vasquez A; Maldonado S; Morán-Mendoza A; Morgan-Villela G; Nagai MA; Navarro-Ruiz N; Oceguera-Villanueva A; Ortiz MA; Quintero J; Quintero-Ramos A; Ramirez-Rosales G; Ramos-Ramirez M; Chiquitelli Marques MM; Rivera Claisse E; Rodriguez-Gonzalez D; Romero-Gomez A; Rosales C; Salas-Gonzalez E; Sanchotena V; Segovia L; Silva-García AA; Valenzuela-Antelo O; Venegas-Godinez L; Zagame L; Gomez J; ; Llera AS; Müller B
JCO Glob Oncol; 2024 May; 10():e2300216. PubMed ID: 38723219
[TBL] [Abstract] [Full Text] [Related]
17. Declination of treatment, Racial and Ethnic Disparity, and Overall Survival in US Patients With breast cancer.
Freeman JQ; Li JL; Fisher SG; Yao KA; David SP; Huo D
JAMA Netw Open; 2024 May; 7(5):e249449. PubMed ID: 38722630
[TBL] [Abstract] [Full Text] [Related]
18. In vitro study on anti-proliferative and anti-cancer activity of picrosides in triple-negative breast cancer.
Soni D; Wahi D; Verma S
Med Oncol; 2024 May; 41(6):143. PubMed ID: 38717628
[TBL] [Abstract] [Full Text] [Related]
19. Acupuncture for the treatment of the pain-fatigue-sleep disturbance-numbness/tingling symptom cluster in breast cancer survivors: a feasibility trial.
Kwon KK; Lacey J; Kerin-Ayres K; Heller G; Grant S
Support Care Cancer; 2024 May; 32(6):332. PubMed ID: 38713422
[TBL] [Abstract] [Full Text] [Related]
20. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
[TBL] [Abstract] [Full Text] [Related]
[Next]
